BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Business

  Resolvyx Pharmaceuticals, Inc. Hires James Nichols as EVP of Corporate Development

  September 10, 2007

   · 

  2 min read
• FDA

  AGA Medical Corporation Receives Approval for the AMPLATZER Muscular Ventricular Septal Defect Occluder

  September 10, 2007

   · 

  2 min read
• Drug Development

  Moberg Derma Starts Recruiting Patients for Phase III Clinical Trial for Its K101 Product Candidate to Treat Nail Fungus

  September 10, 2007

   · 

  1 min read
• Drug Development

  Peregrine Pharmaceuticals, Inc. Submits Clinical Protocol to Initiate Bavituximab Phase II Trial in Patients With Metastatic Breast Cancer

  September 10, 2007

   · 

  5 min read
• Business

  General Wesley Clark Joins Immtech Pharmaceuticals, Inc. as Consulting Strategic Advisor

  September 10, 2007

   · 

  4 min read
• Deals

  BioVascular, Inc. Merges with Revitus and Acquires First-In-Class Platelet Count Reducer

  September 10, 2007

   · 

  3 min read
• Business

  Peregrine Pharmaceuticals, Inc. Reports First Quarter Fiscal Year 2008 Financial Results

  September 10, 2007

   · 

  8 min read
• Resverlogix Corporation: First Ever Therapy Targets Optic Nerve Head for Glaucoma

  September 10, 2007

   · 

  1 min read
• Drug Development

  TapImmune Inc. Announces Initiation of Testing on Novel Cancer Vaccine

  September 10, 2007

   · 

  1 min read
• Drug Development

  IntelGenx Technologies Corp. Proprietary Delivery Technology Tested in Cannasat Therapeutics Inc.’ Phase I Study for Drug Treatment for Neuropathic Pain

  September 10, 2007

   · 

  1 min read